The wide dispersion in mutation frequencies and the absence of BRAF V600E mutations in later studies [59] is probably due to poor interobserver agreements regarding discrimination of DNT from other glioneuronal tumors such as ganglioglioma and probably improper classification of some tumors as DNET [60]. The gene discussed is BRAF; the disease is mixed neuronal-glial tumor.